PROJECTS
>>Ramp up of Product Development Efficiencies
>>Transformation through In-Licensing & Site Transfers
>>Out-License of New Molecular Entity by Biotech Footprint Late
>>Strengthening of Overseas Footprint
>>Divestment of Late Life Cycle Products
>>Commercializing a Reformulated Product
>>Business Development for Development Stage Enabling Technology
>>Restructuring Clinical Operations
>>Optimal Drug Development Path and Licensing Process
>>Post-Merger integration of Research and Development operations
Commercializing a Reformulated Product
Garphi, in conjunction with another associate, worked with a specialty pharmaceutical company to determine the commercial potential of a reformulation of a currently approved product for a new indication. The project consisted of a review of market research, the pharmacokinetic profile of the product, clinical development pipelines, currently marketed products and revenues in the therapeutic area. Key highlights of our work included:
• Interviews with opinion leaders revealed that the pharmacokinetic profile of the product was crucial to defining appropriate market segments.
• A market model was created reflecting uptake in the appropriate market segments and projecting the value of the product in two potential market scenarios. The flexible nature of the model permitted additional scenario testing.
• Garphi prepared a presentation outlining the competitive positioning of the product in the proposed indication relative to other agents both in the clinical development pipeline and on the market.
A launch strategy was firmed up based on Garphi’s findings & recommendations.
